Categoría: Geovanny Vicente

Index takes into account the commitment of companies to greenhouse gas reduction targets

SÃO PAULO, Jan. 6, 2021 /PRNewswire/ — JBS S.A. (the «Company» or «JBS» – B3: JBSS3; OTCQX: JBSAY) in accordance with the terms of CVM Instruction No. 358, dated January 3, 2002, as amended, communicates to its shareholders and to the market in general that once again it was announced as one of the companies selected to be part of the Carbon Efficient Index («ICO2») of the B3, which takes into account the commitment of companies to greenhouse gas reduction targets.

The 2021 edition is the first to encompass companies listed on the IBrX 100 that formally submitted their greenhouse gas emissions inventories to B3. Previously, only those companies that were part of the IBrX 50, that is, the holders of the 50 most exchange-traded shares were invited.

JBS has received important acknowledgements in sustainability

A presence in the Carbon Efficient Index (ICO2) portfolio of B3 is not the only sustainability acknowledgement JBS has received. CDP, the largest and most respected global platform for corporate sustainability information, disclosed on December 8, the results of the reports for 2019, which showed that JBS had advanced in the criteria assessed, occupying the leading position among the Brazilian companies in the Food, Beverage & Tobacco sector.

The Company was assessed on three fronts:  Climate Change; Water Security; and Forests, the latter being subdivided into the categories Wood, Cattle and Soybean.  In 2020, JBS rose from B to A- in Climate Change, reaching leadership level in the issue, and from B- to B in Forests: Soybean, maintaining score B in the other items analyzed.

The advance in the ranking of the Coller FAIRR Protein Producer Index, published in November 2020, was another recent important acknowledgement received by JBS. The Company jumped eight positions in the overall classification (the highest among Brazilian companies listed on B3), growth that clearly demonstrates the commitment of JBS to advance its sustainable practices and transparency.

«This is a very significant validation and a clear demonstration that we are working hard on the transition to the low-carbon economy, in addition to providing the market with increasingly transparent data», points out Márcio Nappo, Sustainability director of JBS.

View original content to download multimedia:http://www.prnewswire.com/news-releases/b3-confirms-jbs-in-the-carbon-efficient-index-301202013.html

SOURCE JBS

NEW YORK, Jan. 6, 2021 /PRNewswire/ — Many children need to take medication at home after being discharged from the hospital. Recent research conducted at the Children’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine found that 70 percent of caregivers either mismanage or don’t fully understand hospital discharge medication instructions, leading to problems such as wrong dosage or confusion about side effects. Now, the same CHAM investigators looked at ways to correct this issue and published their results in Pediatrics. They found medication-related failures can be reduced by almost 50 percent when there is a standardized approach to discharging patients with medications.

«When caregivers are responsible for giving their children medicines at home, it can be confusing and stressful,» said lead author Kaitlyn Philips, DO, assistant medical director of Pediatric Quality, CHAM, and assistant professor of pediatrics, Albert Einstein College of Medicine. «We want children to continue to get better in the comfort of their own home, so it’s vital that caregivers can confidently and safely give medications. Our research shows that when we have a consistent way of educating caregivers, we can reduce the chance that mistakes will be made.»

Dr. Philips is part of a dedicated quality improvement team at CHAM, created to identify issues and implement sustainable fixes to reduce preventable harm and improve patient safety. Supported in part by National Institute of Health grants, she and several other CHAM and Einstein investigators are studying problems affecting patient-care delivery and developing solutions for them. Dr. Philips is also a scholar in the Learning Health System Center of Excellence at Einstein and Montefiore, which provides mentoring and training on how to use data to continuously improve the delivery of care.

For the Pediatrics study, Dr. Philips sought to improve parental knowledge about their child’s medication needs and create clearer instructions to follow at home. She developed and implemented a program called MEDRITES, which stands for: 

• Medication name
• Engagement with the family
• Dose, Route, Indications and Timing
• Expected Effects and side Effects
• Storage counseling and Syringe for accurate administration

Over the 12-month intervention period, caregivers received bedside medication counseling where the provider discussed each topic in MEDRITES in depth. The family also took home improved documentation with clear instructions. Within a week of being discharged, investigators held phone interviews with 249 caregivers, asking how well they understood and were able to follow the discharge instructions. Compared to the 157 patient caregivers interviewed before the program, people who discussed MEDRITES and received improved take-home documentation had better understanding of their child’s medication needs.

MEDRITES has been incorporated into another quality initiative at CHAM called «SAFER Care,» led by Audrey Uong, M.D., attending physician, CHAM, and assistant professor of pediatrics, Einstein. This initiative provides additional discharge guidance for families on topics including: how to prepare children to go back to school; when to follow up with their pediatrician; and what symptoms could indicate signs of relapse. Additionally, MEDRITES is incorporated into annual education for new doctors and several subspecialty providers are adopting a similar process for discharge medication counseling and documentation for their patients.

«The MEDRITES initiative demonstrates that making simple changes, like rounding medication doses to amounts that are appropriate and safe, but also easier to measure, can have a big impact on how children are cared for at home,» said Dr. Philips. «We believe this intervention could be used at hospitals throughout the country to help prevent medication-related errors for children.»

The manuscript is titled MEDRITES: A Project to Improve the Pediatric Inpatient Discharge Medication Process. It is co-authored by Roy Zhou, MD, Diana S. Lee, MD, Christine Marrese, MD, Joanne Nazif, MD, Constance Browne, PharmD, Mark Sinnett, PharmD, Steven Tuckman, BS Pharm, MBA, Anjali Modi, Michael L. Rinke, MD, PhD. The study was supported by the NIH/National Center for Advancing Translational Science (NCATS).

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2020-21 academic year, Einstein is home to 721 M.D. students, 178 Ph.D. students, 109 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2020, Einstein received more than $197 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Follow us on Twitter: @MontefioreNYC        

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-montefiore-study-demonstrates-how-doctors–caregivers-can-partner-to-improve-childrens-care-at-home-after-hospitalization-301202008.html

SOURCE Montefiore Health System; Albert Einstein College of Medicine

MILWAUKEE, Jan. 6, 2021 /PRNewswire/ — Today Circa announces a formal partnership with Washington DC-based DCI Consulting Group, a human resources risk management consulting firm specializing in OFCCP compliance, pay equity, and other workforce analytics. Circa is partnering with DCI to provide its customers and prospects access to high-quality affirmative action planning and other workforce analytic solutions from an industry leading organization.

This partnership aims to improve diversity outcomes across the shared customer base and support federal contractors with their affirmative action and HR consulting planning needs. DCI Consulting and Circa will work together on building resources and providing more options for their clients.

Circa provides OFCCP compliance management and recruiting technology solutions to deliver qualified candidates on a level, equitable playing field that meet organizations’ needs to build high-performing, diverse teams. Circa is expanding their offering through this partnership as customers are seeking a more robust solution from industry leaders. DCI is a recognized expert in systemic compensation discrimination analyses, affirmative action plan development and implementation, pay equity analyses, diversity metrics, employee selection and test validation, and OFCCP audit and litigation support.

«Research, the rebrand of the company, and our new strategic vision support the driving demand for entities seeking diverse workforces,» Patrick Sheahan, CEO, Circa said. «Launching these partnerships complements our core OFCCP and diversity solutions and helps customers with turn-key solutions that help them build high-performing teams and accelerate their success.» 

With 20 years of experience, DCI Consulting Group is an industry leader in providing Affirmative Action Plan solutions, pay equity, and workforce analytic solutions. They form strategic partners with their clients to leverage data for meaningful analyses that drive organizational change. Their wide array of services can support clients in preparing audit-ready Affirmative Action Plans, actionable pay equity studies, and their industry-experts will assist in navigating audits. DCI clients have unparalleled access to analytic solutions. They also provide metrics for diversity, equity, and inclusion studies, personnel selection, and litigation support.

«Thought leadership and continued growth are values at DCI. We are excited to partner with Circa for the opportunities to create additional resources and share knowledge with our clients as well as the opportunity to share our services with a broader market,» David Cohen, President of DCI Consulting.

To drive mutual success, Circa will showcase DCI Consulting products and services to customers and prospects, feature them in marketing events and on the company’s website, and work with them on thought leadership content.

About Circa

Circa is a catalyst for 21st century companies to build high-performing diverse teams based on research that shows companies want to shift from diversity as a program to diversity as a business strategy. The companies’ robust portfolio of software solutions and unparalleled industry expertise give employers the tools and knowledge they need to radically change how they approach talent acquisition and management. The company was founded in 1994, has 4500+ customers, 15,500 community partner relationships and in 2019 posted 5M+ jobs through its network of 600+ online employment websites.

About DCI

DCI Consulting Group is a human resources compliance, data analytics, and litigation support firm. DCI leverages its expertise in industrial and organizational psychology and labor economics to understand its client’s organizational challenges and to identify strategic solutions. DCI Consulting is strategically located in Washington, D.C. Since 2001, DCI has provided expert solutions to hundreds of employers on the complex issues of Equal Employment Opportunity (EEO) compliance. Members of their consulting staff are recognized experts in systemic compensation discrimination analyses, affirmative action plan development and implementation, pay equity analyses, employee selection and test validation, and OFCCP audit and litigation support.

Media Contact
Katie Saba
Product Marketing Manager
288537@email4pr.com
800.984.3775
Circaworks.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/circa-announces-partnership-with-aap-provider-dci-consulting-group-301201526.html

SOURCE Circa

NEW YORK, Jan. 6, 2021 /PRNewswire/ — Zoe Financial takes a look back at everything experienced in 2020 and how the market responded helps provide some insight into the current state of the markets and the economy, as well as how it could be changing in the near future. In 2020, the market experienced the fastest decline in history, the quickest resurgence since 1933, and a global pandemic in scale and severity not seen in over a century.

Unprecedented Market Volatility

The market started out strong in 2020, with 71% of companies beating their expected earnings through February 7th. The S&P 500 continued to grow and peaked at 3386 on February 19, 2020. However, the COVID-19 pandemic swept through the nation in February. From February 19, 2020 to March 20, 2020, the S&P 500 dropped nearly 32%, which was a faster decline than the market experienced during the Great Depression, the market crash in 1987, and the 2008 financial crisis.

Bonds Rally

The Bond market did not escape the volatility, with the treasury market seeing the largest intraday moves in over 35 years in March. The combination of a flight to safety and the anticipation that both monetary and fiscal policy were going to use every tool in their arsenal led to a massive Treasury bond rally.

In fact, the 10-year Treasury bond yield hit a new all-time low of 0.31% on March 8.

Although the rate of decline the market experienced this year was unprecedented, the market bounced back quicker than anyone expected. By June 5, 2020, the S&P 500 was only down 2% from the beginning of the year, and the Dow Jones Industrial Average was down only 4.5% from the start of the year. In fact, by late March, the Dow saw the best surge in a single day since 1933.

After the resurgence, the market began to slow again, slightly falling throughout September and October. This was most likely due to the rise in COVID-19 cases and the resulting fears of a «double dip recession» and the uncertainty surrounding the presidential election that was approaching. In October, the S&P 500 experienced its worst week since March, falling 3.5%. 

In November, the S&P 500 rose 10.75%, the Dow Jones Industrial Average rose 11.84%, and the Nasdaq rose 11.8%. This jump in the market was mostly driven by the positive results of the COVID-19 vaccine trials that suggested the vaccine could be available by the first half of 2021. The possibility of the vaccine meant that economic activity could resume quicker than expected. The presidential election was also in November, which many investors were waiting for to determine their investment decisions. 

The Winners and Losers

Despite the fact that broad indexes rallied back to double digits, the market did discriminate between Covid winners and losers. Sectors that benefited from the shift of consumers to digital channels such as Online retail and Tech stocks rose significantly while «off-line» sectors like Airlines and Energy suffered significant losses.

The Global Economy Halted…and Bounced Back

From an economic standpoint, it is fair to say that the global economy grinded to a halt. For instance, the Global Purchasing Manager (PMI) Index for services around the world all fell to the worst levels seen since 2008. As the below chart shows, equally surprising is the significant improvement as the year progresses with Global PMI ending up in expansion territory as of November.

Needless to say, 2020 was a standout year due to its unpredictability. From starting the year with a global pandemic to ending it with a vaccine, the markets up in double digits, and an economic recovery underway; it is fair to say the year delivered a decade into 12 months. Looking at 2020 in review, this past year taught us that predicting the markets when investing is a fool’s errand. 2020 also reinforced the value of  maintaining a diversified portfolio. A well-diversified portfolio (as seen in the Asset Class Returns chart below) that holds stocks, bonds, and even commodities would have yielded approximately 8% returns with much lower volatility, than just owning stocks.

About Zoe Financial

Zoe Financial’s award-winning algorithm enables individuals to discover and connect with highly vetted, top fiduciary advisors in their area. All financial advisors in the Zoe Network are vetted and verified fiduciaries, along with having top credentials, education, and experience. Zoe’s service provides support from start to finish during an individual’s financial advisor search. All consultation calls and interviews with Zoe’s network of advisors are completely free and are offered via video chat or traditional phone call depending on an individual’s preference.

Press Contact:
press@zoefin.co

View original content to download multimedia:http://www.prnewswire.com/news-releases/market-wrap-up-what-we-learned-in-2020-301201640.html

SOURCE Zoe Financial